ImageneBio Stock Forward View - Price Action Indicator

IMA Stock   7.29  0.07  0.95%   
ImageneBio Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ImageneBio stock prices and determine the direction of ImageneBio's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ImageneBio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of ImageneBio's share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of ImageneBio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with ImageneBio, which may create opportunities for some arbitrage if properly timed.
Using ImageneBio hype-based prediction, you can estimate the value of ImageneBio from the perspective of ImageneBio response to recently generated media hype and the effects of current headlines on its competitors.

ImageneBio after-hype prediction price

    
  USD 7.31  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ImageneBio to cross-verify your projections.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.

ImageneBio Additional Predictive Modules

Most predictive techniques to examine ImageneBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ImageneBio using various technical indicators. When you analyze ImageneBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
ImageneBio has current Price Action Indicator of 0.025. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check ImageneBio VolatilityBacktest ImageneBioInformation Ratio  

ImageneBio Trading Date Momentum

On February 10 2026 ImageneBio was traded for  7.29  at the closing time. Highest ImageneBio's price during the trading hours was 7.42  and the lowest price during the day was  7.04 . The net volume was 40.8 K. The overall trading history on the 10th of February did not cause price change. The trading delta at closing time to current price is 1.65% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare ImageneBio to competition

Other Forecasting Options for ImageneBio

For every potential investor in ImageneBio, whether a beginner or expert, ImageneBio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ImageneBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ImageneBio. Basic forecasting techniques help filter out the noise by identifying ImageneBio's price trends.

ImageneBio Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImageneBio stock to make a market-neutral strategy. Peer analysis of ImageneBio could also be used in its relative valuation, which is a method of valuing ImageneBio by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ImageneBio Market Strength Events

Market strength indicators help investors to evaluate how ImageneBio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImageneBio shares will generate the highest return on investment. By undertsting and applying ImageneBio stock market strength indicators, traders can identify ImageneBio entry and exit signals to maximize returns.

ImageneBio Risk Indicators

The analysis of ImageneBio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ImageneBio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting imagenebio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for ImageneBio

The number of cover stories for ImageneBio depends on current market conditions and ImageneBio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ImageneBio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ImageneBio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

ImageneBio Short Properties

ImageneBio's future price predictability will typically decrease when ImageneBio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ImageneBio often depends not only on the future outlook of the potential ImageneBio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ImageneBio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48.3 M
Cash And Short Term Investments124.4 M
When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:
Check out Historical Fundamental Analysis of ImageneBio to cross-verify your projections.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.